Page last updated: 2024-10-24

camostat and Pancreatic Fistula

camostat has been researched along with Pancreatic Fistula in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Pancreatic Fistula: Abnormal passage communicating with the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with omeprazole (15 mumol/kg) to suppress gastric acid secretion or with L-364,718 (5 mumol/kg) to antagonize CCK receptors in the diverted state, resulted in the decline in pancreatic secretion similar to that observed after opening the GF."1.28Feedback control of pancreatic secretion in rats. Role of gastric acid secretion. ( Bilski, J; Konturek, PK; Konturek, SJ; Krzyzek, E, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilski, J1
Konturek, PK1
Krzyzek, E1
Konturek, SJ1

Other Studies

1 other study available for camostat and Pancreatic Fistula

ArticleYear
Feedback control of pancreatic secretion in rats. Role of gastric acid secretion.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1992, Volume: 43, Issue:3

    Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Esters; Feedback; Gabexate; Gastric Acid; G

1992